Invention Grant
- Patent Title: Pharmaceutical composition for preventing or treating hearing loss comprising oat extract as an active ingredient
-
Application No.: US16133033Application Date: 2018-09-17
-
Publication No.: US11033598B2Publication Date: 2021-06-15
- Inventor: Hyong Ho Cho , Hyung Seok Kim , Sung Su Lee , Yu Young Lee
- Applicant: INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY , CHONNAM NATIONAL UNIVERSITY HOSPITAL , REPUBLIC OF KOREA(MANAGEMENT : RURAL DEVELOPMENT ADMINISTRATION)
- Applicant Address: KR Gwangju; KR Gwangju; KR Jeollabuk-do
- Assignee: INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY,CHONNAM NATIONAL UNIVERSITY HOSPITAL,REPUBLIC OF KOREA(MANAGEMENT : RURAL DEVELOPMENT ADMINISTRATION)
- Current Assignee: INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY,CHONNAM NATIONAL UNIVERSITY HOSPITAL,REPUBLIC OF KOREA(MANAGEMENT : RURAL DEVELOPMENT ADMINISTRATION)
- Current Assignee Address: KR Gwangju; KR Gwangju; KR Jeollabuk-do
- Agency: The PL Law Group, PLLC
- Priority: KR10-2016-0031516 20160316,KR10-2016-0121291 20160922
- Main IPC: A61K36/899
- IPC: A61K36/899 ; A61K36/00 ; A61K45/06 ; A61K31/167 ; A61K31/196 ; A61P27/16

Abstract:
A method for preventing or treating hearing loss includes administering a composition comprising an oat extract to a subject. The method may use avenanthramide or a derivative thereof an oat extract. The oat extract has an effect on hair cells of the cochlea, spinal ganglion cells, and angiocytes, and an effect of inhibiting occurrence of hearing loss and can be usefully used for preventing or treating hearing loss. In particular, since the oat extract is a natural product and has stability without cytotoxicity, the composition containing the oat extract as an active ingredient has a safety advantage for long-term use without side effects on the human body.
Public/Granted literature
Information query